Abstract
Abnormalities in coagulation and fibrinolysis are frequently observed in septic shock. The most pronounced clinical manifestation is disseminated intravascular coagulation. Recent studies in human volunteers and animal models have clarified the early dynamics and route of activation of both coagulation and fibrinolytic pathways. In healthy subjects subjected to a low dose of either endotoxin or TNF an imbalance in the procoagulant and the fibrinolytic mechanisms is apparent, resulting in a procoagulant state. Also in patients with septic shock a dynamic process of coagulation and fibrinolysis is ongoing with evidence of impaired fibrinolysis. These abnormalities have prognostic significance; the extent of disturbances of coagulation and fibrinolysis is related to the development of multiple organ failure and death.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P (1992) Septic shock, multiple organ failure, and disseminated intravascular coagulation. Chest 101:816–823
Leclerc F, Hazelzet J, Jude B, Hofhuis W, Hue V, Marinot A, Van der Voort E (1992) Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases. Intensive Care Med 18:202–205
Coalson JJ (1986) Pathology of sepsis, septic shock and multiple organ failure. In: Sibbald WJ, Sprung CL (eds) Perspectives on sepsis and septic shock. New Horizons SCCM: p 27–59
Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV (1986) Multiple-organ-failure syndrome. Arch Surg 121:196–208
Tanaka T, Tsujinaka T, Kambayashi J, Higashiyama M, Yokota M, Sakon M, Mori T (1990) The effect of heparin on multiple organ failure and disseminated intravascular coagulation in a sepsis model. Thromb Res 60:321–330
Colman RW (1992) The role of the kallikrein-kinin system in septic shock. In: Lamy M, Thijs LG (eds) Mediators of sepsis. Update in intensive care and emergency medicine, vol 16. Springer, Berlin Heidelberg New York, p 99–112
Taylor FB jr (in press) Studies on the natural history and mechanism of the primate (baboon) response toE. coli. In: Morrison DC, Ryan JL (eds) Bacterial endotoxic lipopolysaccharides, vol II. CRC Press, Boca Raton, Florida
Furie B, Furie BC (1992) Molecular and cellular biology of blood coagulation. N Engl J Med 326:800–806
Harris KW, Esmon CT (1985) Protein S is required for bovine platelets to support activated protein C binding and activity. J Biol Chem 260:2007–2011
Kruithof EKO, Nocoloso G, Bachmann F (1987) Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood 70:1645–1653
Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU (1987) Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 79:124–130
Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N (1983) Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 71:1893–1896
Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr (1984) Interleukin-1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelail cells. J Exp Med 160:618–623
Nawroth PP, Stern DM (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163:740–745
Bevilacqua MP, Pober JS, Majeau GR, Fiers RW, Cotran RS, Gimbrone MA Jr (1986) Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin-1. Proc Natl Acad Sci USA 83:4533–4537
Conway EM, Back R, Rosenberg RD, Koningsberg WH (1989) Tumor necrosis factor enhances expression of tissue factor in RNA in endothelial cells. Thromb Res 53:231–241
Nawroth PP, Handley DA, Esmon CT, Stern DM (1986) Interleukin-1 induces endothelial cell procoagulant while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA 83:3460–3464
Moore KL, Esmon CT, Esmon NL (1989) Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine anti endothelial cells in culture. Blood 73:159–165
Conway EM, Rosenberg RD (1988) Tumor necrosis factor suppresses transcription of thrombomodulin gene in endothelial cells. Mol Cell Biol 8:5588–5592
Emeis JJ, Kooistra T (1986) Interleukin-1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 163:1260–1266
Hanss M, Collen D (1987) Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine. J Lab Clin Med 109:97–104
Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr, Loskutoff DJ (1988) Cytokine activation of vascular endothelium: effects on tissue-type plasminogen activator and type I plasminogen activator inhibitor. J Biol Chem 263:5797–5803
Van Hinsbergh VWM, Van den Berg EA, Fiers W, Dooijewaard G (1990) Tumor necrosis factor induces the production of urokinasetype plasminogen activator by human endothelial cells. Blood 75:1991–1996
Colluci M, Paramo JA, Collen D (1985) Generation in plasma of a fast acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 75:818–824
Gelehrter TD, Sznycer-Laszuk R (1986) Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J Clin Invest 77:165–169
Hoylaerts M, Rijken DC, Lijnen HR, Collen D (1982) Kinetics of the activation of plasminogen activator: role of fibrin. J Biol Chem 257:2912–2919
Wojta J, Hoover RL, Daniel TO (1989) Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produced large amounts of single chain urokinase type plasminogen activator. J Biol Chem 264:2846–2852
Heaton JH, Dame MK, Gelehrter TD (1992) Thrombin induction of plasminogen activator inhibitor mRNA in human umbilical vein endothelial cells in culture. J Lab Clin Med 120:222–228
Shumann MA (1986) Thrombin-cellular interactions. Ann NY Acad Sci 485:228–239
Suffredini AF, Harpel PC, Parrillo JE (1989) Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 320:1165–1172
Van Deventer SJH, Büller HR, Ten Cate JW, Aarden LA, Hack CE, Sturk A (1990) Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520–2526
Wolff SM (1973) Biological effects of bacterial endotoxins in man. J Infect Dis 128:259–264
Mastich GD, Danner RL, Ceska M, Suffredini AF (1991) Detection of interleukin-8 and tumor necrosis factor in normal humans following intravenous endotoxin: the effect of anti-inflammatory agents. J Exp Med 173:1021–1024
Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MA Jr, Shires GT, Lowry SF (1988) Cytokine appearance in human endotoxia and primate bacteremia. Surg Gynecol Obstet 166:147–153
De La Cadena RA, Suffredini AF, Kaufman N, Parrillo JE, Colman RW (1990) Activation of the kalikrein-kinin system after endotoxin administration to normal human volunteers. Clin Res 38:346A
Van der Poll T, Büller HR, Ten Cate H, Wortel CH, Bauer KA, Van Deventer SJH, Hack CE, Sauerwein HP, Rosenberg RD, Ten Cate JW (1990) Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 322:1622–1627
Van der Poll T, Levi M, Büller HR, Van Deventer SJH, De Boer JP, Hack CE, Ten Cate JW (1991) Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 174:729–732
Bauer KA, Ten Cate H, Barzeger S, Spriggs DR, Sherman ML, Rosenberg RD (1989) Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 74:165–172
Van Hinsbergh VWM, Bauer KA, Kooistra T, Kluft C, Dooijewaard G, Sherman ML, Nieuwenhuizen W (1990) Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products. Blood 76:2284–2289
Smith-Erichsen N, Aasen AO, Gallimore MJ, Amudsen E (1982) Studies of components of the coagulation systems in normal individuals and septic shock patients. Circ Shock 9:491–497
Voss R, Matthias FR, Borkowski G, Reitz D (1990) Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol 75:99–105
Hesselvik JF, Blombäck M, Brodin B, Maller R (1989) Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med 17:724–733
Takahashi H, Tatewaki W, Wada K, Hanano M, Shibata A (1990) Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol 33:90–95
Hesselvik JF, Malm J, Dahlbäck B, Blombäck M (1991) Protein C, Protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 65:126–129
Okajima K, Yang WP, Okabe H, Inoue M, Takatsuki K (1991) Role of leukocytes in the activation of intravascular coagulation in patients with septicemia. Am J hematol 36:265–271
De Boer JP, Creasy AA, Chang A, Roem D, Brouwer MC, Eerenberg AJM, Hack CE, Taylor FB Jr (1993) Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal and sublethal dose ofE. coli. Circ Shock 39:59–67
Creasy AA, Stevens P, Kenney J, Allison AC, Warren K, Catlett R, Hinshaw L, Taylor FB Jr (1991) Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethalEscherichia coli. Circ Shock 33:84–91
Nuijens JH, Huijbregts CCM, Eerenberg AJM, Abbink JJ, Strack van Schijndel RJM, Felt-Bersma RJF, Thijs LG, Hack CE (1988) Quantification of plasma factor XIIa-C1 inhibitor and kallikrein-C1 inhibitor complexes in sepsis. Blood 72:487–493
Schorer AE, Rick PD, Swaim WR, Moldow CF (1985) Structural features of endotoxin required for stimulation of endothelial cell tissue factor production; exposure of preformed tissue factor after oxidant-mediated endothelial cell injury. J Lab Clin Med 106:38–42
Osterund B, Flægstad T (1983) Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Hemost 49:5–7
Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS (1991) LethalE. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 33:127–134
Philipé J, Offner F, Declerck PJ, Leroux-Roels G, Vogelaers D, Baele G, Collen D (1991) Fibrinolysis and coagulation in patients with infectious disease and sepsis. Thromb Hemost 65:291–295
Brandtzaeg P, Sandset PM, Joo GB, Ovstebo R, Abildgaard U, Kierulf P (1989) The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 55:459–470
Wilson RF, Mammen EF, Robson MC, Heggers JP, Soullier G, DePoli PA (1985) Antithrombin, prekallikrein, and fibronectin levels in surgical patients. Arch Surg 121:635–640
Seitz R, Wolf M, Egbring R, Radtke KP, Liesenfeld A, Pittmer P (1987) Participation and interaction of neutrophil elastase in haemostatic disorders of patients with severe infections. Eur J Haematol 38:231–240
Jordan RE, Nelson RM, Kilpatrick J, Newgren JO, Esmon PC, Fournel MA (1989) Antithrombin inactivation by neutrophil elastase requires heparin. Am J Med 87:3B19S-3B22S
Marlar RA, Endres-Brooks J, Miller C (1985) Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 66:59–63
Fourrier F, Lestavel P, Chopin C, Marey A, Goudemand J, Rime A, Mangalaboyi J (1990) Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates. Intensive Care Med 16:121–124
Blanco A, Guisaola JA, Solis P, Bachiller R, Gonzalez H (1990) Fibronectin in meningococcal sepsis: correlation with antithrombin III and protein C. Acta Paediatr Scand 79:73–76
Taylor FB Jr, Emerson TE Jr, Jordan R, Chang AK, Blick KE (1988) Antithrombin-III prevents the lethal effects ofEscherichia coli infusion in baboons. Circ Shock 26:227–235
Taylor FB Jr, Chang A, Esmon Ct, D'Angelo A, Vigano-D'Angelo S, Blick KE (1987) Protein C prevents the coagulopathic and lethal effects ofEscherichia coli infusion in the baboons. J Clin Invest 79:918–925
Taylor FB Jr, Chang A, Ferrell G, Mather T, Catlett R, Blick K, Esmon CT (1991) C4b-binding protein exacerbates the host response toEscherichia coli. Blood 78:357–363
Taylor FB Jr, Chang ACK, Peer GT, Mather T, Blick K, Catlett R, Lockhart MS, Esmon CT (1991) DEGR-factor Xa blocks disseminated intravascular coagulation initiated byEscherichia coli without preventing shock or organ damage. Blood 78:364–368
Brandtzaeg P, Joo GB, Brusletto B, Kierulf P (1990) Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res 57:271–278
Pralong G, Calandra T, Glauser MP, Schellekens J, Verhoef J, Bachmann F, Kruithof EKO (1989) Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost 61:459–462
Hekman CM, Loskutoff DJ (1989) Endothelial cells produce a latent inhibitor of plasminogen that can be associated by denaturants. J Biol Chem 260:11581–11587
Lindahl TL, Sigurdardoffir O, Wiman B (1989) Stability of plasminogen activator inhibitor 1 (PAI-1). Thromb Haemost 62:748–751
Kruithof EKO (1988) Plasminogen activator inhibitor type 1: biochemical, biological and clinical aspects. Fibrinolysis 2:59–70
Lawrence DA, Loskutoff DJ (1986) Inactivation of plasminogen activator inhibitor by oxidants. Biochemistry 25:6351–6355
Stief TW, Martin E, Caso F, Rodriquez JM (1990) Oxidation susceptibility of plasminogen activator inhibitors in human plasma. Thromb Res 60:177–180
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thijs, L.G., de Boer, J.P., de Groot, M.C.M. et al. Coagulation disorders in septic shock. Intensive Care Med 19 (Suppl 1), S8–S15 (1993). https://doi.org/10.1007/BF01738944
Issue Date:
DOI: https://doi.org/10.1007/BF01738944